These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 4017423)
1. Effects of age and disease on the pharmacokinetics and pharmacodynamics of sulindac. Sitar DS; Owen JA; MacDougall B; Hunter T; Mitenko PA Clin Pharmacol Ther; 1985 Aug; 38(2):228-34. PubMed ID: 4017423 [TBL] [Abstract][Full Text] [Related]
2. Sulindac metabolism: the importance of an intact colon. Strong HA; Warner NJ; Renwick AG; George CF Clin Pharmacol Ther; 1985 Oct; 38(4):387-93. PubMed ID: 4042521 [TBL] [Abstract][Full Text] [Related]
9. Biliary secretion of sulindac and metabolites in man. Dobrinska MR; Furst DE; Spiegel T; Vincek WC; Tompkins R; Duggan DE; Davies RO; Paulus HE Biopharm Drug Dispos; 1983; 4(4):347-58. PubMed ID: 6661513 [TBL] [Abstract][Full Text] [Related]
10. Effect of uremia and anephric state on the pharmacokinetics of sulindac and its metabolites in rats. I. An application of pharmacokinetic model for reversible metabolism. Lin JH; Yeh KC; Duggan DE Drug Metab Dispos; 1985; 13(5):602-7. PubMed ID: 2865111 [TBL] [Abstract][Full Text] [Related]
11. A kinetic study of sulindac in the elderly. Bayley N; Warne RW; Moulds RF; Bury RW Aust N Z J Med; 1987 Feb; 17(1):39-42. PubMed ID: 3476045 [TBL] [Abstract][Full Text] [Related]
12. Individual variability in concentrations of urinary sulindac sulfide. Brandli DW; Sarkissian E; Ng SC; Paulus HE Clin Pharmacol Ther; 1991 Dec; 50(6):650-5. PubMed ID: 1752108 [TBL] [Abstract][Full Text] [Related]
13. Sulindac: therapeutic implications of the prodrug/pharmacophore equilibrium. Duggan DE Drug Metab Rev; 1981; 12(2):325-37. PubMed ID: 7040018 [TBL] [Abstract][Full Text] [Related]
14. Ibuprofen and sulindac kinetics in alcoholic liver disease. Juhl RP; Van Thiel DH; Dittert LW; Albert KS; Smith RB Clin Pharmacol Ther; 1983 Jul; 34(1):104-9. PubMed ID: 6861431 [TBL] [Abstract][Full Text] [Related]
16. Effect of uremia and anephric state on the pharmacokinetics of sulindac and its metabolites in rats. II. Differential effects on the biliary excretion. Lin JH; Yeh KC; Duggan DE Drug Metab Dispos; 1985; 13(5):608-13. PubMed ID: 2865112 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and dialyzability of sulindac and metabolites in patients with end-stage renal failure. Ravis WR; Diskin CJ; Campagna KD; Clark CR; McMillian CL J Clin Pharmacol; 1993 Jun; 33(6):527-34. PubMed ID: 8366178 [TBL] [Abstract][Full Text] [Related]
18. Sulindac is not renal sparing in man. Roberts DG; Gerber JG; Barnes JS; Zerbe GO; Nies AS Clin Pharmacol Ther; 1985 Sep; 38(3):258-65. PubMed ID: 4028619 [TBL] [Abstract][Full Text] [Related]
20. A comparison of benoxaprofen and sulindac in patients with rheumatoid arthritis and osteoarthritis. Roth SH Eur J Rheumatol Inflamm; 1982; 5(2):258-69. PubMed ID: 7044801 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]